These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 21306569

  • 1. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.
    Ambrose CS, Levin MJ, Belshe RB.
    Influenza Other Respir Viruses; 2011 Mar; 5(2):67-75. PubMed ID: 21306569
    [Abstract] [Full Text] [Related]

  • 2. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.
    Carter NJ, Curran MP.
    Drugs; 2011 Aug 20; 71(12):1591-622. PubMed ID: 21861544
    [Abstract] [Full Text] [Related]

  • 3. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR, Lone NI, Kavanagh K, Englishby T, Robertson C, McMenamin J, Wissman BV, Vasileiou E, Butler CC, Ritchie LD, Gunson R, Schwarze J, Sheikh A.
    Health Technol Assess; 2020 Dec 20; 24(67):1-66. PubMed ID: 33256892
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.
    Vaccine; 2009 Feb 11; 27(7):1101-10. PubMed ID: 19095024
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.
    Belshe RB, Toback SL, Yi T, Ambrose CS.
    Influenza Other Respir Viruses; 2010 May 01; 4(3):141-5. PubMed ID: 20409210
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
    Ambrose CS, Wu X, Knuf M, Wutzler P.
    Vaccine; 2012 Jan 20; 30(5):886-92. PubMed ID: 22155144
    [Abstract] [Full Text] [Related]

  • 7. Seasonal influenza vaccines.
    Fiore AE, Bridges CB, Cox NJ.
    Curr Top Microbiol Immunol; 2009 Jan 20; 333():43-82. PubMed ID: 19768400
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM.
    J Infect Dis; 2011 Nov 15; 204(10):1475-82. PubMed ID: 21949042
    [Abstract] [Full Text] [Related]

  • 9. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
    Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, Truscott SM, Abate G, Sakala IG, Edwards KM, Creech CB, Gerber MA, Bernstein DI, Newman F, Graham I, Anderson EL, Belshe RB.
    J Infect Dis; 2011 Sep 15; 204(6):845-53. PubMed ID: 21846636
    [Abstract] [Full Text] [Related]

  • 10. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.
    He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, Lewis DB, Dekker CL, Greenberg HB, Arvin AM.
    J Virol; 2006 Dec 15; 80(23):11756-66. PubMed ID: 16971435
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 15; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.
    Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O.
    J Infect Dis; 2014 Jul 15; 210(2):224-33. PubMed ID: 24495909
    [Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
    Ambrose CS, Dubovsky F, Yi T, Belshe RB, Ashkenazi S.
    Eur J Clin Microbiol Infect Dis; 2012 Oct 15; 31(10):2549-57. PubMed ID: 22410646
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination.
    Ambrose CS, Wu X, Belshe RB.
    Pediatr Infect Dis J; 2010 Sep 15; 29(9):806-11. PubMed ID: 20458256
    [Abstract] [Full Text] [Related]

  • 16. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany.
    Falkenhorst G, Harder T, Remschmidt C, Terhardt M, Zepp F, Ledig T, Wicker S, Keller-Stanislawski B, Mertens T.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov 15; 56(11):1557-64. PubMed ID: 24170085
    [Abstract] [Full Text] [Related]

  • 17. Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines.
    Ramakrishnan A, Althoff KN, Lopez JA, Coles CL, Bream JH.
    Cytokine; 2012 Dec 15; 60(3):661-6. PubMed ID: 22989940
    [Abstract] [Full Text] [Related]

  • 18. T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.
    Weinberg A, Song LY, Fenton T, Nachman SA, Read JS, Patterson-Bartlett J, Levin MJ.
    AIDS Res Hum Retroviruses; 2010 Jan 15; 26(1):51-9. PubMed ID: 20059397
    [Abstract] [Full Text] [Related]

  • 19. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z, Tobler S, Roayaei J, Eick A.
    JAMA; 2009 Mar 04; 301(9):945-53. PubMed ID: 19255113
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.
    Vaccine; 2008 Jun 02; 26(23):2841-8. PubMed ID: 18462851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.